Identification of genetic disparity between primary and metastatic melanoma in human patients.
about
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib.Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology.Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.α-Catulin downregulates E-cadherin and promotes melanoma progression and invasion.MET expression in melanoma correlates with a lymphangiogenic phenotype.Intratumor and Intertumor Heterogeneity in Melanoma.
P2860
Identification of genetic disparity between primary and metastatic melanoma in human patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Identification of genetic disp ...... ic melanoma in human patients.
@en
Identification of genetic disp ...... ic melanoma in human patients.
@nl
type
label
Identification of genetic disp ...... ic melanoma in human patients.
@en
Identification of genetic disp ...... ic melanoma in human patients.
@nl
prefLabel
Identification of genetic disp ...... ic melanoma in human patients.
@en
Identification of genetic disp ...... ic melanoma in human patients.
@nl
P2093
P2860
P356
P1476
Identification of genetic disp ...... ic melanoma in human patients.
@en
P2093
Alexander Swoboda
Doris Rasin-Streden
Hubert Pehamberger
Ichiro Okamoto
Oliver Schanab
P2860
P304
P356
10.1002/GCC.20890
P577
2011-05-16T00:00:00Z